tiprankstipranks
Trending News
More News >
BriaCell Therapeutics Corp (BCTX)
NASDAQ:BCTX
US Market

BriaCell Therapeutics (BCTX) Financial Statements

Compare
322 Followers

BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently $26.81M. The company's EPS TTM is $-4.383606114; its P/E ratio is -0.09; BriaCell Therapeutics is scheduled to report earnings on December 11, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -147.89KC$ -114.04KC$ -20.49KC$ -19.39KC$ -19.44K
Operating IncomeC$ -37.73MC$ -46.02KC$ -23.27MC$ -15.29MC$ -6.97M
EBITDAC$ -36.63MC$ -45.91KC$ -27.23MC$ -34.05MC$ -6.95M
Net IncomeC$ -36.50MC$ -6.62KC$ -20.30MC$ -11.58MC$ -2.90M
Balance Sheet
Cash & Short-Term InvestmentsC$ 17.87MC$ 862.09KC$ 21.25MC$ 41.04MC$ 57.27M
Total AssetsC$ 21.65MC$ 5.87MC$ 27.16MC$ 42.58MC$ 58.04M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 25.99K
Net DebtC$ -10.49MC$ -862.09KC$ -21.25MC$ -41.04MC$ -57.24M
Total LiabilitiesC$ 4.32MC$ 8.56MC$ 30.94MC$ 32.25MC$ 782.24K
Stockholders' EquityC$ 24.72MC$ -2.38MC$ -3.78MC$ 10.33MC$ 57.26M
Cash Flow
Free Cash FlowC$ -28.17MC$ -24.58MC$ -23.74MC$ -12.48MC$ -7.75M
Operating Cash FlowC$ -28.17MC$ -24.13MC$ -23.74MC$ -12.48MC$ -7.75M
Investing Cash FlowC$ -7.65MC$ -681.80KC$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 45.45MC$ 4.42MC$ 3.95MC$ -3.74MC$ 65.00M
Currency in CAD

BriaCell Therapeutics Earnings and Revenue History

BriaCell Therapeutics Debt to Assets

BriaCell Therapeutics Cash Flow

BriaCell Therapeutics Forecast EPS vs Actual EPS